Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Aug 27, 2024; 16(8): 2474-2483
Published online Aug 27, 2024. doi: 10.4240/wjgs.v16.i8.2474
Figure 1
Figure 1 Receiver operating characteristic curve of dynamic positron emission tomography parameters in gastric cancer and esophageal cancer. A: Receiver operating characteristic curve of dynamic positron emission tomography parameters in gastric cancer; B: Receiver operating characteristic curve of dynamic positron emission tomography parameters in esophageal cancer. MR: Metabolic rate; LBR: Lesion/background ratio; ROC: Receiver operating characteristic; DV: Volume distribution.
Figure 2
Figure 2 A patient with gastric signet-ring cell carcinoma underwent 18F-fluorodeoxyglucose-positron emission tomography/computed tomography for initial staging. A: Computed tomography; B: 18F-fluorodeoxyglucose-FAPI-positron emission tomography/computed tomography; C: 68Ga-positron emission tomography/computed tomography. FDG: Fluorodeoxyglucose. Arrow: Tumor location.
Figure 3
Figure 3 Subcutaneous and bone metastases of gastric cancer were identified by 18F-fluorodeoxyglucose positron emission tomography/computed tomography. FDG: Fluorodeoxyglucose. Arrow: Tumor location.